MedTrace Logo

Analysis of the Electrical Muscle Activity and Resistance to Movement in Spastic Hemiparetic Patients.

NCT01945151 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-09-18

No results posted yet for this study

Summary

To evaluate and compare the effects of Neuromuscular Electrical Stimulation when applied in the agonist and antagonist muscles of spastic hemiparetic patients.

The specific objectives are:

* Evaluate the resistance movement, strength and muscle electrical activity before and after application of Neuromuscular Electrical Stimulation in spastic muscle (gastrocnemius).
* Evaluate the resistance movement, strength and muscle electrical activity before and after application of Neuromuscular Electrical Stimulation in the spastic antagonist muscle (tibialis anterior).
* Compare the risk of falls after application of Neuromuscular Electrical Stimulation in both muscles studied.

Conditions

  • Cerebrovascular Accident

Interventions

OTHER

Group 2 (G2) NMES is applied in the spastic muscle (gastrocnemius).

The G2 apply NMES in the gastrocnemius motor point and the rest will be done during stretching of the gastrocnemius muscle (autogenic inhibition). Five consecutive sessions will be held in the morning and afternoon in the laboratory of Sensory Motor Rehabilitation Engineering.

Sponsors & Collaborators

  • Universidade do Vale do Paraíba

    lead OTHER

Principal Investigators

  • Sergio ST Takeshi, pesquisador · Universidade do Vale do Paraíba

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
45 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-06-30
Primary Completion
2013-09-30
Completion
2013-11-30

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01945151 on ClinicalTrials.gov